|Bid||0.2560 x 0|
|Ask||0.3380 x 0|
|Day's range||0.2960 - 0.3040|
|52-week range||0.2660 - 1.0465|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||13 Nov 2023 - 17 Nov 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Fortress Biotech (FBIO) delivered earnings and revenue surprises of -10.53% and 23.98%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 7.41% and 13.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?